Tutorials: Jan 1, 2012 (Vol. 32, No. 1)

Metabolomics Impacts Biomanufacturing

Finding Applications in the Improvement of Protein Production and Processing Operations

(Page 1 of 2)

    Figure 1. Cell culture cGMP manufacturing at Sandoz in Schaftenau, Austria
    Click To Enlarge +

    Figure 1. Cell culture cGMP manufacturing at Sandoz in Schaftenau, Austria

    Many recombinant therapeutic proteins such as monoclonal antibodies are produced in eukaryotic cells to enable post-translational modifications such as glycosylation. Glycan profiles and charge variants are important quality attributes for the activity, efficacy, and safety of therapeutic proteins.

    To meet these parameters highly efficient and targeted media development is crucial. Whereas systematic approaches such as QbD are increasingly applied, a deeper understanding of the interaction between metabolic alterations, protein production, and processing should significantly improve production processes (Figure 1).

    Metabolomics is a valuable tool to study underlying mechanisms and involved biochemical pathways—especially for the widely used CHO cell line, for which little is known about its physiology.

    In this tutorial we will show how we evaluated the potential of metabolomic tools to support cell-line characterization and subsequent process development, this information was also recently presented at the ESACT meeting in Vienna. As part of the study, we compared a CHO producer and its corresponding mock cell line (transfected with an empty plasmid) on a metabolic level in order to see whether the metabolite profile differences came from the increased protein production capacity. In addition, we were able to observe the complex glycosylation machinery.

    Figure 2. Overview of the key steps for adequate quenching of mammalian cells in suspension
    Click To Enlarge +

    Figure 2. Overview of the key steps for adequate quenching of mammalian cells in suspension

    Sample-Prep Optimization

    First, studies dealing with optimization of sample preparation—more precisely the sampling procedure called quenching—were conducted. This step is responsible for the mandatory immediate stopping of enzymatical reactions in order to preserve the intracellular metabolite environment and can strongly affect subsequent results.

    We developed a simple and straightforward protocol, with no need for special equipment, that focuses on the efficiency of stopping metabolic activities and the potential metabolic leakage due to the loss in membrane integrity.

    Within this protocol, it is recommended that cells are quenched and washed simultaneously to keep sampling time to a minimum and to prevent further metabolic activity within the cells. Studies also showed that by using this procedure additional washing steps can be omitted. A detailed description of the studies will be published elsewhere. An overview of the key steps of the implemented sampling procedure, which allows simultaneous quenching of a large number of samples, is illustrated in Figure 2.


Related content

GEN News Highlights

Insight & Intelligence™

GEN Articles

BLOG biotech

Webinars

GEN Podcasts

Video Channel

New Products

Best of the Web

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA Performance

How much progress do you think FDA has made in reviewing drugs and bringing them to market faster?

Suggest a Poll